Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132886) titled 'Research on Blood Transfusion Risk Prediction for Critically Ill Patients Based on Artificial Intelligence' on Sept. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The second affiliated hospital of Zhejiang University school of medicine
Condition:
Critically ill
Intervention:
Experimental Group (Model-guided group:The AI system will be activated. Based on a dynamic assessment of the patient's MODS risk, it will provide the attending doctor with clear, personalized transfusion recommendations (for example: 'Transfusion recommended, expected benefit > risk' or 'Observation reco...